How best to estimate the global burden of pertussis?

被引:164
作者
Crowcroft, NS
Stein, C
Duclos, P
Birmingham, M
机构
[1] Hlth Protect Agcy Communicable Dis Surveillance, Immunisat Div, London NW9 5EQ, England
[2] World Hlth Org, Vaccine Assessment & Monitoring Team Vaccines & B, Geneva, Switzerland
关键词
D O I
10.1016/S1473-3099(03)00669-8
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In most countries, pertussis surveillance is inadequate for accurately estimating numbers of cases or deaths. Good estimates are needed to help set priorities for vaccination programmes. We aimed to develop a simple, reliable, and explicit method for estimating pertussis cases and deaths for children under 15 years to calculate the global disease burden in 1999. We estimated the proportion of susceptible children becoming infected in countries with poor vaccination coverage (<70%) in 1999 at 30% by 1 year, 80% by 5 years, and 100% by 15 years of age and for countries with good coverage (greater than or equal to70%) at 10% by 1 year, 60% by 5 years, and 100% by 15 years. Vaccine efficacy was estimated at 80% for preventing infection and 95% for preventing deaths. We used UN population estimates and vaccination coverage reported to WHO (adjusted for specific survey data if available). Case fatality ratios for countries with high and low child mortality were derived from published and unpublished work. For some countries with good vital events registration we used reported deaths adjusted for underascertainment. In 1999 there were an estimated 48.5 million pertussis cases in children worldwide. Deaths from pertussis were estimated at 390 000 and at 295 000 after adjustment for local data sources. Based on this approach, disability-adjusted life years from pertussis (12.7 million) in 2000 exceeded those of other preventable diseases such as lung cancer (11.4 million) and meningitis (5.8 million). This simple approach yields estimates that can be used for setting vaccination programme priorities. Better data are needed on the public health importance of pertussis in high mortality countries, the benefits of incomplete vaccination, and the harm from delayed vaccination.
引用
收藏
页码:413 / 418
页数:6
相关论文
共 63 条
[31]  
Milord F, 1995, Can Commun Dis Rep, V21, P40
[32]  
*MIN HLTH SULT OM, 1997, SURV ADV EV FOLL IMM
[33]  
MORLEY D, 1966, TROP GEOGR MED, V18, P169
[34]  
MULLER AS, 1984, B WORLD HEALTH ORGAN, V62, P899
[35]  
Murray C. J. L., 1996, GLOBAL BURDEN DIS CO
[36]  
MURRAY CJL, 2001, 36 WHO GLOB PROG EV
[37]  
Navarrete-Navarro S, 1990, Bol Med Hosp Infant Mex, V47, P304
[38]   EPIDEMIOLOGY OF PERTUSSIS IN DENMARK - THE IMPACT OF HERD-IMMUNITY [J].
NIELSEN, A ;
LARSEN, SO .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 1994, 23 (06) :1300-1308
[39]   Randomised controlled trial of two-component, three-component, and five-component acellular pertussis vaccines compared with whole-cell pertussis vaccine [J].
Olin, P ;
Rasmussen, F ;
Gustafsson, L ;
Hallander, HO ;
Heijbel, H .
LANCET, 1997, 350 (9091) :1569-1577
[40]   Epidemiology of pertussis in a West African community before and after introduction of a widespread vaccination program [J].
Préziosi, MP ;
Yam, A ;
Wassilak, SGF ;
Chabirand, L ;
Simaga, A ;
Ndiaye, M ;
Dia, M ;
Dabis, F ;
Simondon, F .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 155 (10) :891-896